Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (2): 231-236.doi: 10.19982/j.issn.1000-6621.20240424
• Review Articles • Previous Articles Next Articles
Fu Ying1, Xiong Yangyang1, Fang Si2, Li Chuanxiang2, Guo Hongrong2()
Received:
2024-09-24
Online:
2025-02-10
Published:
2025-02-08
Contact:
Guo Hongrong, Email: hyg6808@sina.com
Supported by:
CLC Number:
Fu Ying, Xiong Yangyang, Fang Si, Li Chuanxiang, Guo Hongrong. The research progress on the relationship between serum albumin and its derivative biomarkers and chronic obstructive pulmonary disease[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 231-236. doi: 10.19982/j.issn.1000-6621.20240424
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20240424
[1] | Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J, 2023, 61(4): 2300239. doi:10.1183/13993003.00239-2023. |
[2] | 邱巧静, 陶洋, 沈佳妮, 等. 慢性阻塞性肺疾病症状群及其与患者生活质量的相关性研究. 结核与肺部疾病杂志, 2024, 5(3): 219-224. doi:10.19983/j.issn.2096-8493.2024067. |
[3] |
Ritchie AI, Wedzicha JA. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med, 2020, 41(3): 421-438. doi:10.1016/j.ccm.2020.06.007.
pmid: 32800196 |
[4] | GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990—2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020, 396(10258): 1204-1222. doi:10.1016/S0140-6736(20)30925-9. |
[5] |
Ramakrishnan S. Chronic obstructive pulmonary disease: 10 years of precision-guided success. Lancet Respir Med, 2023, 11(3): 227-228. doi:10.1016/S2213-2600(23)00013-9.
pmid: 36863785 |
[6] | 胡冰. 慢性阻塞性肺疾病和支气管哮喘诊治及社区慢病管理指导. 中国防痨杂志, 2024, 46(5): 604. doi:10.3969/j.issn.1000-6621.2024.05.019. |
[7] | Ling M, Huiyin L, Shanglin C, et al. Relationship between human serum albumin and in-hospital mortality in critical care patients with chronic obstructive pulmonary disease. Front Med (Lausanne), 2023, 10: 1109910. doi:10.3389/fmed.2023.1109910. |
[8] | Ferdous F, Raqib R, Ahmed S, et al. Early childhood malnutrition trajectory and lung function at preadolescence. Public Health Nutr, 2021, 24(5): 1009-1020. doi:10.1017/S1368980019004853. |
[9] | Zinellu E, Fois AG, Sotgiu E, et al. Serum Albumin Concentrations in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. J Clin Med, 2021, 10(2): 269. doi:10.3390/jcm10020269. |
[10] | Chen D, Jiang L, Li J, et al. Interaction of Acute Respiratory Failure and Acute Kidney Injury on in-Hospital Mortality of Patients with Acute Exacerbation COPD. Int J Chron Obstruct Pulmon Dis, 2021, 16: 3309-3316. doi:10.2147/COPD.S334219. |
[11] | Lai KJ, Hsieh YP, Chiu PF, et al. Association of Albumin and Globulin with Mortality Risk in Incident Peritoneal Dialysis Patients. Nutrients, 2022, 14(14): 2850. doi:10.3390/nu14142850. |
[12] | Cho Y, Park SB, Yoon JY, et al. Neutrophil to lymphocyte ratio can predict overall survival in patients with stage Ⅱ to Ⅲ colorectal cancer. Medicine (Baltimore), 2023, 102(11): e33279. doi:10.1097/MD.0000000000033279. |
[13] | 王赛男, 刘剑波, 韩校鹏, 等. 血白蛋白与球蛋白比值对慢性阻塞性肺疾病急性加重期患者预后评估的价值. 中国临床新医学, 2020, 13(1): 48-52. doi:10.3969/j.issn.1674-3806.2020.01.11. |
[14] |
Qin J, Qin Y, Wu Y, et al. Application of albumin/globulin ratio in elderly patients with acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis, 2018, 10(8): 4923-4930. doi:10.21037/jtd.2018.07.47.
pmid: 30233866 |
[15] | Yu Y, Wu W, Dong Y, et al. C-Reactive Protein-to-Albumin Ratio Predicts Sepsis and Prognosis in Patients with Severe Burn Injury. Mediators Inflamm, 2021, 2021: 6621101. doi:10.1155/2021/6621101. |
[16] | Kang P, Kang W, Li Y, et al. C-Reactive Protein-to-Albumin Ratio as an Early Biomarker to Identify Sepsis in Neonates with Pneumonia. Mediators Inflamm, 2022, 2022: 4711018. doi:10.1155/2022/4711018. |
[17] | Li H, Ma Y, Xue J, et al. C-Reactive Protein to Serum Albumin Ratio as a Novel Biomarker to Predict Prognosis in Patients with Chronic Obstructive Pulmonary Disease. Clin Lab, 2021, 67(3). doi:10.7754/Clin.Lab.2020.200630. |
[18] | Shen S, Xiao Y. Association Between C-Reactive Protein and Albumin Ratios and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2289-2303. doi:10.2147/COPD.S413912. |
[19] | Baldemir R, Öztürk A, Eraslan Doganay G, et al. Evaluation of Nutritional Status in Hospitalized Chronic Obstructive Pulmonary Disease Patients and Can C-reactive Protein-to-Albumin Ratio Be Used in the Nutritional Risk Assessment in These Patients. Cureus, 2022, 14(2): e21833. doi:10.7759/cureus.21833. |
[20] | Giri M, He L, Hu T, et al. Blood Urea Nitrogen Is Associated with In-Hospital Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis. J Clin Med, 2022, 11(22): 6709. doi:10.3390/jcm11226709. |
[21] |
Peng X, Huang Y, Fu H, et al. Prognostic Value of Blood Urea Nitrogen to Serum Albumin Ratio in Intensive Care Unit Patients with Lung Cancer. Int J Gen Med, 2021, 14: 7349-7359. doi:10.2147/IJGM.S337822.
pmid: 34737629 |
[22] |
Han T, Cheng T, Liao Y, et al. Analysis of the Value of the Blood Urea Nitrogen to Albumin Ratio as a Predictor of Mortality in Patients with Sepsis. J Inflamm Res, 2022, 15: 1227-1235. doi:10.2147/JIR.S356893.
pmid: 35558187 |
[23] | Alirezaei T, Hooshmand S, Irilouzadian R, et al. The role of blood urea nitrogen to serum albumin ratio in the prediction of severity and 30-day mortality in patients with COVID-19. Health Sci Rep, 2022, 5(3): e606. doi:10.1002/hsr2.606. |
[24] | 石齐芳, 盛鹰, 杨光耀, 等. 尿素氮与白蛋白比值对慢性阻塞性肺疾病急性加重有创机械通气患者住院病死率的预测价值. 临床急诊杂志, 2021, 22(2): 98-102. doi:10.13201/j.issn.1009-5918.2021.02.004. |
[25] | Zeng Z, Ke X, Gong S, et al. Blood urea nitrogen to serum albumin ratio: a good predictor of in-hospital and 90-day all-cause mortality in patients with acute exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med, 2022, 22(1): 476. doi:10.1186/s12890-022-02258-7. |
[26] | 古冬容, 张越旻. 血尿素氮与白蛋白比值对慢性阻塞性肺疾病急性加重期预后情况的预测价值. 中外医学研究, 2023, 21(26): 61-64. doi:10.14033/j.cnki.cfmr.2023.26.016. |
[27] | Gong Y, Li D, Cheng B, et al. Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock. Epidemiol Infect, 2020, 148: e87. doi:10.1017/S0950268820000771. |
[28] | Yu Y, Liu Y, Ling X, et al. The Neutrophil Percentage-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Cardiogenic Shock. Biomed Res Int, 2020, 2020: 7458451. doi:10.1155/2020/7458451. |
[29] | Wang B, Li D, Cheng B, et al. The Neutrophil Percentage-to-Albumin Ratio Is Associated with All-Cause Mortality in Critically Ill Patients with Acute Kidney Injury. Biomed Res Int, 2020, 2020: 5687672. doi:10.1155/2020/5687672. |
[30] | 袁瑶, 黄娟, 钟磊, 等. 中性粒细胞百分比与白蛋白比值对慢性阻塞性肺病患者预后判断的价值. 全科医学临床与教育, 2021, 19(11): 1023-1025. doi:10.13558/j.cnki.issn1672-3686.2021.011.020. |
[31] | Lan CC, Su WL, Yang MC, et al. Predictive role of neutrophil-percentage-to-albumin, neutrophil-to-lymphocyte and eosinophil-to-lymphocyte ratios for mortality in patients with COPD: Evidence from NHANES 2011—2018. Respirology, 2023, 28(12): 1136-1146. doi:10.1111/resp.14589. |
[32] | Wang H, Zhou H, Jiang R, et al. Globulin, the albumin-to-globulin ratio, and fibrinogen perform well in the diagnosis of Periprosthetic joint infection. BMC Musculoskelet Disord, 2021, 22(1): 583. doi:10.1186/s12891-021-04463-7. |
[33] | 罗兵, 孙敏捷, 霍星星, 等. 纤维蛋白原与清蛋白比值在急性加重期慢性阻塞性肺疾病诊断中的应用. 国际检验医学杂志, 2019, 40(22): 2708-2712. doi:10.3969/j.issn.1673-4130.2019.22.005. |
[34] | 南黎, 王华, 葛廷. 纤维蛋白原与白蛋白比值对慢阻肺急性加重风险的预测价值分析. 实用中西医结合临床, 2022, 22(11): 76-79, 120. doi:10.13638/j.issn.1671-4040.2022.11.023. |
[35] | Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci, 2015, 52(2): 86-105. doi:10.3109/10408363.2014.992064. |
[36] | Qiu Y, Wang Y, Shen N, et al. Association Between Red Blood Cell Distribution Width-Albumin Ratio and Hospital Mortality in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit: A Retrospective Study. Int J Chron Obstruct Pulmon Dis, 2022, 17: 1797-1809. doi:10.2147/COPD.S371765. |
[37] | 柴卫芳, 段小凯, 樊实真, 等. RDW/ALB值对COPD急性加重期患者临床预后的预测分析. 河南医学研究, 2023, 32(24): 4456-4460. doi:10.3969/j.issn.1004-437X.2023.24.010. |
[38] | Chen XL, Xue L, Wang W, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget, 2015, 6(38): 41370-82. doi:10.18632/oncotarget.5629. |
[39] | Farag CM, Antar R, Akosman S, et al. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types. Oncotarget, 2023, 14: 153-172. doi:10.18632/oncotarget.28367. |
[40] | Han H, Hu S, Du J. Predictive value of the hemoglobin-albumin-lymphocyte-platelet (HALP) index for ICU mortality in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Intern Emerg Med, 2023, 18(1): 85-96. doi:10.1007/s11739-022-03132-4. |
[41] | 马玲, 王志贤, 罗兵. HALP指数对老年慢性阻塞性肺疾病急性加重期患者出院后30d内非计划再入院的预测价值. 实用心脑肺血管病杂志, 2024, 32(2):20-23. doi:10.12114/j.issn.1008-5971.2024.00.028. |
[42] | Johannet P, Sawyers A, Qian Y, et al. Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer. J Immunother Cancer, 2020, 8(2): e001674. doi:10.1136/jitc-2020-001674. |
[43] | Correa-Rodríguez M, Pocovi-Gerardino G, Callejas-Rubio JL, et al. The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus. Nutrients, 2019, 11(3): 638. doi:10.3390/nu11030638. |
[44] | 李凤, 刘海月, 林益华, 等. 炎症、营养指标与AECOPD患者合并低蛋白血症的相关性分析. 重庆医学, 2024, 53(4): 517-521. doi:10.3969/j.issn.1671-8348.2024.04.008. |
[45] | Scoditti E, Massaro M, Garbarino S, et al. Role of Diet in Chronic Obstructive Pulmonary Disease Prevention and Treatment. Nutrients, 2019, 11(6): 1357. doi:10.3390/nu11061357. |
[46] | Zhou Z, Wang Y, Wang Y, et al. A Diagnostic Nomogram for Predicting Hypercapnic Respiratory Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis, 2024, 19: 1079-1091. doi:10.2147/COPD.S454558. |
[47] | Peng JC, Nie F, Li YJ, et al. Prognostic Nutritional Index as a Predictor of 30-Day Mortality Among Patients Admitted to Intensive Care Unit with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Single-Center Retrospective Cohort Study. Med Sci Monit, 2022, 28: e934687. doi:10.12659/MSM.934687. |
[48] | Yuan FZ, Xing YL, Xie LJ, et al. The Relationship Between Prognostic Nutritional Indexes and the Clinical Outcomes of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis, 2023, 18: 1155-1167. doi:10.2147/COPD.S402717. |
[49] | Gao H, Cheng X, Zuo X, et al. Exploring the Impact of Adequate Energy Supply on Nutrition, Immunity, and Inflammation in Elderly Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis, 2024, 19: 1391-1402. doi:10.2147/COPD.S450209. |
[1] | Liu Yiping, Lin Youfei, Chen Xiaohong, Pan Jianguang. A case of pulmonary Castleman disease prone to misdiagnosis: a literature review [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 921-929. |
[2] | Wang Yutong, Liu Yuhong, Li Liang. Research progress on psychological and psychiatric adverse reactions induced by antituberculosis drugs [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 947-953. |
[3] | Shi Jie, Chang Wenjing, Zheng Danwei, Su Ruyue, Ma Xiaoguang, Zhu Yankun, Wang Shaohua, Sun Jianwei, Sun Dingyong. Screening of core genes and pathways involved in tuberculosis onset based on GEO database [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 769-778. |
[4] | Zhang Peize, Gao Qian, Deng Guofang. [18F]FDT-PET-CT technology that may bring revolutionary changes to tuberculosis clinical research [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 262-265. |
[5] | You Chengdong, Zhu Ling, Li Peibo. Research progress on serum trace elements in the development and nutritional support of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 218-223. |
[6] | Li Wenhan, Yang Jing, Li Chunhua. Research progress of artificial intelligence in pulmonary tuberculosis imaging diagnosis and drug resistance prediction [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1098-1103. |
[7] | He Xiangrong, Chen Hua, Chen Pinru, Liang Feng, Ren Huili, Zhu Jialou, Hu Jinxing, Tan Yaoju. A case report and literature review of Mycobacterium asiaticum pulmonary disease [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 763-769. |
[8] | Xu Wenhui, Zhang Yanqiu, Shi Jie, Sun Dingyong. Advances in biomarker research for tuberculosis diagnosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 713-721. |
[9] | Shang Xuetian, Dong Jing, Huang Mailing, Sun Qi, Jia Hongyan, Zhang Lanyue, Liu Qiuyue, Yao Mingxu, Wang Yingchao, Ji Xiuxiu, Du Boping, Xing Aiying, Pan Liping. Transcriptome study on peripheral blood mononuclear cells of latent tuberculosis infection individuals [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 449-460. |
[10] | Shang Xuetian, Pan Liping. Role of tissue kallikrein family in pathogenesis of microorganism infection [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 239-244. |
[11] | Chen Yujie, Wang Linghua, Cheng Xiaoyan, Li Huiyuan. Research progress on latent tuberculosis infection in medical staff [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1541-1547. |
[12] | He Jing, Zhang Zhongfa. Research progress on mixed infection in pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1566-1572. |
[13] | Li Chaofan, Chen Zhi. Advances in the application of animal models and 3D cell models in tuberculosis research [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1527-1534. |
[14] | Wang Yujin, Chu Naihui, Nie Wenjuan. Research progress in the treatment of tuberculosis with contezolid [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1395-1399. |
[15] | Yan Hongxuan, Yuan Jinfeng, Wang Yilin, Pang Yu, Gao Mengqiu. Advances in the host-directed therapy of tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1273-1282. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||